# CorFlow Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/corflow-therapeutics

- Industry: Medical Devices & Equipment
- Headquarters: Baar, Switzerland
- Website: www.corflow-therapeutics.ch
- Total disclosed funding: $49M
- Latest round: Series B (Sep 10, 2024)
- Investors on record: 10

## About

Based in Baar-Zug, Switzerland, and founded in 2016 and led by Chief Executive Officer Paul Mead, CorFlow Therapeutics AG is a developer of diagnostic and therapeutic medical devices for the treatment of microvascular obstructions in heart attack patients. In September 2024, CorFlow Therapeutics AG raised EUR 2 million in Series B funding co-led by Broadview Ventures, Panakes Partners, and many more. 

CorFlow Therapeutics AG developed the CoFl system, which is a diagnostic and therapeutic solution for microvascular obstruction (MVO), particularly in heart attack patients. The company’s system CoFl system is designed to diagnose MVO in real-time and deliver localized therapeutic agents directly to the microvasculature, supporting patient outcomes post-stent implantation. In addition, the firm’s system integrates into standard workflows utilizing existing guide catheter and wire access. 

The company plans to use the funding from September 2024 to accelerate the MOCA II (MVO with CoFI System Assessment II) pivotal study intended to gain US market clearance.

## Funding rounds

- Series B, Sep 10, 2024, $49M — Wellington Partners, Broadview Ventures, Merieux Equity Partners, Monte Carlo Capital, Panakes Partners, 415 CAPITAL, KOFA Healthcare Investments, Unorthodox Ventures, Laerdal Million Lives Fund, M&L Healthcare

## Investors

- Wellington Partners (https://capitalatlas.ai/funds/wellington-partners) — Series B
- Broadview Ventures (https://capitalatlas.ai/funds/broadview-ventures) — Series B
- Merieux Equity Partners (https://capitalatlas.ai/funds/merieux-equity-partners) — Series B
- Monte Carlo Capital (https://capitalatlas.ai/funds/monte-carlo-capital) — Series B
- Panakes Partners (https://capitalatlas.ai/funds/panakes-partners) — Series B
- 415 CAPITAL (https://capitalatlas.ai/funds/415-capital) — Series B
- KOFA Healthcare Investments (https://capitalatlas.ai/funds/kofa-healthcare-investments) — Series B
- Unorthodox Ventures (https://capitalatlas.ai/funds/unorthodox-ventures) — Series B
- Laerdal Million Lives Fund (https://capitalatlas.ai/funds/laerdal-million-lives-fund) — Series B
- M&L Healthcare — Series B